CIK 0000860730 · Large accelerated filer
HCA Healthcare, Inc.
Sign in to watch- Ticker
- HCA
- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 273865930
- Phone
- 6153449551
- Business address
- ONE PARK PLZ, NASHVILLE, TN, 37203
- Former names
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,251,400
- in 3 filings
Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-03 | HAZEN SAMUEL N CEO | Shares withheld for taxes | −32,208 | $258.08 | $8.3M | 105,677 |
| 2023-02-03 | HAZEN SAMUEL N CEO | Option exercise · Stock Appreciation Right | −59,000 | 0 | ||
| 2023-02-03 | Akdamar Erol R Group President | Option exercise | +9,000 | $45.30 | $408K | 43,726 |
| 2023-02-03 | Akdamar Erol R Group President | Shares withheld for taxes | −3,932 | $258.08 | $1.0M | 39,794 |
| 2023-02-03 | Akdamar Erol R Group President | Option exercise · Stock Appreciation Right | −9,000 | 0 | ||
| 2023-02-03 | RUTHERFORD BILL B CFO and EVP | Sale | −30,000 | $258.19 | $7.7M | 81,632 |
| 2023-02-02 | Akdamar Erol R Group President | Sale | −3,000 | $258.63 | $776K | 34,726 |
| 2023-02-01 | RUTHERFORD BILL B CFO and EVP | Option exercise | +37,000 | $68.96 | $2.6M | 119,527 |
| 2023-02-01 | RUTHERFORD BILL B CFO and EVP | Option exercise | +27,000 | $69.58 | $1.9M | 146,527 |
| 2023-02-01 | RUTHERFORD BILL B CFO and EVP | Shares withheld for taxes | −34,895 | $261.46 | $9.1M | 111,632 |
| 2023-02-01 | RUTHERFORD BILL B CFO and EVP | Option exercise · Stock Appreciation Right | −37,000 | 0 | ||
| 2023-02-01 | RUTHERFORD BILL B CFO and EVP | Option exercise · Stock Appreciation Right | −27,000 | 19,100 | ||
| 2023-02-01 | Wyatt Christopher F. SVP & Controller | Sale | −4,900 | $253.30 | $1.2M | 32,392 |
| 2023-02-01 | Whalen Kathleen M SVP & Chief Ethics Officer | Shares withheld for taxes | −586 | $255.07 | $149K | 11,696 |
| 2023-02-01 | Paslick P. Martin SVP and CIO | Sale | −1,000 | $256.95 | $257K | 3,000 |
| 2023-02-01 | Foster Jon M EVP and COO | Sale | −16,424 | $251.98 | $4.1M | 10,938 |
| 2023-02-01 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale | −4,000 | $257.11 | $1.0M | 20,822.55 |
| 2023-01-31 | Wyatt Christopher F. SVP & Controller | Gift | −379 | 37,292 | ||
| 2023-01-31 | Whalen Kathleen M SVP & Chief Ethics Officer | Gift | −341 | 11,032 | ||
| 2023-01-31 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise | +1,250 | $69.58 | $87K | 12,282 |
Page 27 of 56 · 1,102 trades